Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Jabookie75on Apr 06, 2022 1:12pm
198 Views
Post# 34581145

Very sad to see this

Very sad to see thisI have long been out of this stock but have kept it on my watchlist as I hoped it would amount to something.  I was buying this close to $2.00 several years ago ($16.00 split adjusted price today) and took a ride all the way down to 0.01 with it.  Lost a good chunk of change.  Even called Leslie Auld (former CFO) on the day it hit 0.01 to see if they were closing the doors and declaring bankruptcy.  She had no clue the share price had come that close to going to $0..  Company was called Genenews back then.

I bought the hype the last time this ran to 1.60 and had a nice gain at that price with a 0.90 or so cost basis.  They had analyst coverage and everything looked good but I always had that nagging feeling that they might disappoint with an earnings call. They sure did.  Sold out at 1.10 and lost most of my profits.  Oh well.  I did not see red this time!!

I am astounded at how they can continue to secure financing with this kind of sharehloder value destruction.  This sell off has to be someone big selling out who bought a PP at much higher prices and has just said fack it and will sell for pennies on the dolalr now.

JHT does not deserve his salary and should resign.  This guy probably lives a very cushy life off the backs of shareholders and financers and has delivered nothing.  Very very sad company.
<< Previous
Bullboard Posts
Next >>